You are requesting information on: Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes
Already a member of Bioprocess Online or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: